GranuFlo Lawsuits Mount, as Bernstein Liebhard LLP Notes Filing of New Claim in Alabama Alleging Wrongful Death from GranuFlo Side Effects

The Firm is investigating GranuFlo lawsuits on behalf of dialysis patients who allegedly suffered catastrophic and life-threatening heart events related to the administration of GranuFlo or NaturaLyte dialysis concentrates.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
This GranuFlo lawsuit puts forth allegations similar to those contained in hundreds of other claims pending in courts around the country.

New York, NY (PRWEB) March 07, 2014

GranuFlo lawsuits (http://www.thegranuflolawsuit.com/) alleging injury and death due to the administration of GranuFlo or NaturaLyte dialysis concentrates continue to mount in courts around the country, Bernstein Liebhard LLP reports. According to court documents, the daughter of one such patient filed a wrongful death lawsuit in U.S. District Court, Southern District of Alabama on January 31, 2014, that claims her mother’s death from severe adverse cardiac events was the result of GranuFlo. (Case No. 2:2014cv00039)

“This GranuFlo lawsuit puts forth allegations similar to those contained in hundreds of other claims pending in courts around the country. The complaint also echoes what we have heard from many of our own clients who were allegedly injured by GranuFlo or NaturaLyte,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free legal reviews to dialysis patients who allegedly suffered cardiac arrest, heart attacks, stroke, sudden cardiac death or other serious heart events within 72 hours of the administration of GranuFlo or NaturaLyte.

GranuFlo Recall
GranuFlo and NaturaLyte are both dialysis concentrates manufactured by Fresenius Medical Care. The products are used during dialysis treatments to remove toxins from the blood in patients suffering from kidney failure. Both were recalled in June 2012, following the release of an Urgent Product Notification by Fresenius which detailed dosing issues that could result in the onset of potentially deadly cardiovascular events. The U.S. Food & Drug Administration (FDA) designated the notification a Class I GranuFlo recall, its most serious type of recall.

According to court documents, more than 500 GranuFlo lawsuits have been filed in courts around the country since the announcement of the GranuFlo and NaturaLyte recall. The majority of these claims have been filed in a multidistrict litigation now underway in U.S. District Court, District of Massachusetts (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428) Additional lawsuits have been consolidated at the state level in Massachusetts’ Middlesex County Superior Court. (In re Consolidated Fresenius Cases, No. MICV2013-03400-O).

All of the GranuFlo lawsuits pending in these litigations accuse Fresenius of failing to provide adequate warnings regarding the potential for GranuFlo and NaturaLyte to cause deadly heart side effects. According to court documents, the claims point out that in November 2011, Fresenius Medical Care issued a memo to its own dialysis clinics regarding the risks associated with GranuFlo and NaturaLyte. However, nothing was done at that time to notify thousands of dialysis centers outside the Fresenius network about the potential dangers associated with the products.

Individuals who allegedly suffered serious heart events following the administration of GranuFlo or NaturaLyte may be entitled to compensation from Fresenius Medical Care. Learn more about the GranuFlo recall by visiting Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For more information, and to arrange for a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.thegranuflolawsuit.com/
https://plus.google.com/115936073311125306742?rel=author